TSH Resources Berhad Valuation

Is TSH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TSH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TSH (SGD0.33) is trading below our estimate of fair value (SGD1.01)

Significantly Below Fair Value: TSH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for TSH?

Other financial metrics that can be useful for relative valuation.

TSH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.6x
Enterprise Value/EBITDA5.9x
PEG Ratio2.1x

Price to Earnings Ratio vs Peers

How does TSH's PE Ratio compare to its peers?

The above table shows the PE ratio for TSH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.8x
P8Z Bumitama Agri
7.3x-1.7%S$1.3b
EB5 First Resources
9.7x3.1%S$2.3b
E5H Golden Agri-Resources
23.5x32.9%S$3.6b
5JS Indofood Agri Resources
6.7xn/aS$439.7m
TSH TSH Resources Berhad
15.4x7.2%S$1.5b

Price-To-Earnings vs Peers: TSH is expensive based on its Price-To-Earnings Ratio (15.4x) compared to the peer average (11.8x).


Price to Earnings Ratio vs Industry

How does TSH's PE Ratio compare vs other companies in the Asian Food Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.3%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.3%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: TSH is good value based on its Price-To-Earnings Ratio (15.4x) compared to the Asian Food industry average (17.5x).


Price to Earnings Ratio vs Fair Ratio

What is TSH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TSH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.4x
Fair PE Ratio8.9x

Price-To-Earnings vs Fair Ratio: TSH is expensive based on its Price-To-Earnings Ratio (15.4x) compared to the estimated Fair Price-To-Earnings Ratio (8.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TSH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentS$0.33
S$0.35
+6.0%
6.2%S$0.39S$0.32n/a9
Oct ’25S$0.34
S$0.35
+1.4%
6.2%S$0.39S$0.32n/a9
Sep ’25S$0.35
S$0.35
-0.03%
6.2%S$0.39S$0.32n/a9
Aug ’25S$0.34
S$0.33
-3.0%
11.7%S$0.39S$0.29n/a8
Jul ’25S$0.34
S$0.34
+0.6%
10.9%S$0.39S$0.29n/a8
Jun ’25S$0.32
S$0.34
+7.0%
10.9%S$0.39S$0.29n/a8
May ’25S$0.33
S$0.31
-4.5%
8.7%S$0.37S$0.28n/a8
Apr ’25S$0.33
S$0.31
-4.5%
8.7%S$0.37S$0.28n/a8
Mar ’25S$0.29
S$0.31
+5.2%
8.7%S$0.37S$0.28n/a8
Feb ’25S$0.29
S$0.31
+7.6%
8.7%S$0.37S$0.28n/a8
Jan ’25S$0.28
S$0.31
+13.5%
8.7%S$0.37S$0.28n/a8
Dec ’24S$0.28
S$0.31
+9.5%
8.7%S$0.37S$0.28n/a8
Nov ’24S$0.28
S$0.30
+7.9%
4.4%S$0.32S$0.28n/a7
Oct ’24S$0.29
S$0.30
+2.3%
4.4%S$0.32S$0.28S$0.347
Sep ’24n/a
S$0.30
0%
4.4%S$0.32S$0.28S$0.357
Aug ’24n/a
S$0.30
0%
5.4%S$0.32S$0.27S$0.347
Jul ’24n/a
S$0.30
0%
5.2%S$0.32S$0.27S$0.348
Jun ’24n/a
S$0.31
0%
6.5%S$0.35S$0.28S$0.329
May ’24n/a
S$0.36
0%
11.3%S$0.41S$0.28S$0.339
Apr ’24n/a
S$0.36
0%
11.3%S$0.41S$0.28S$0.339
Mar ’24n/a
S$0.36
0%
11.3%S$0.41S$0.28S$0.299
Feb ’24n/a
S$0.38
0%
12.2%S$0.46S$0.31S$0.299
Jan ’24n/a
S$0.36
0%
16.2%S$0.45S$0.26S$0.289
Dec ’23n/a
S$0.36
0%
16.2%S$0.45S$0.26S$0.289
Nov ’23n/a
S$0.42
0%
27.3%S$0.59S$0.26S$0.288
Oct ’23n/a
S$0.42
0%
27.3%S$0.59S$0.26S$0.298

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies